Glomeria Therapeutics, an Italian company specialized in innovative therapeutic devices for renal patients and Fineheart developing an innovative cardiac assistance device have been selected among 20 over hundreds of candidates to reach next step of the Big Booster competition heading to Boston USA. Both companies are lead investment of Sofimac Partners Venture Technology Portfolio.

“This important international acknowledgment indicates the quality of the selection of our portfolios …”says Mario Caria International Director of Sofimac Partners, who is ”… proud and confident that the opportunity will give the adequate visibility to the companies for reaching overseas partnerships..”

 

bigbooster

BigBooster is proud to present you the class of 2017

http://bigbooster.org/class2017.php